Keene & Associates, Inc. Avanos Medical, Inc. Transaction History
Keene & Associates, Inc.
- $130 Million
- Q3 2024
A detailed history of Keene & Associates, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Keene & Associates, Inc. holds 18,165 shares of AVNS stock, worth $293,546. This represents 0.33% of its overall portfolio holdings.
Number of Shares
18,165
Previous 18,635
2.52%
Holding current value
$293,546
Previous $371,000
17.52%
% of portfolio
0.33%
Previous 0.31%
Shares
11 transactions
Others Institutions Holding AVNS
# of Institutions
274Shares Held
42.2MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$86 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$51.3 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$41.9 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$38.3 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $751M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...